Lyell Immunopharma, Inc. (LYEL)
NASDAQ: LYEL · IEX Real-Time Price · USD
2.360
-0.040 (-1.67%)
At close: May 3, 2024, 4:00 PM
2.535
+0.175 (7.42%)
After-hours: May 3, 2024, 5:30 PM EDT
Lyell Immunopharma Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Lyell Immunopharma stock have an average target of 5.50, with a low estimate of 5.00 and a high estimate of 6.00. The average target predicts an increase of 133.05% from the current stock price of 2.36.
Analyst Consensus: Buy
* Price targets were last updated on Feb 29, 2024.
Analyst Ratings
The average analyst rating for LYEL stock from 2 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 3 | 3 | 3 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $8 → $6 | Strong Buy | Maintains | $8 → $6 | +154.24% | Feb 29, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $9 → $8 | Strong Buy | Maintains | $9 → $8 | +238.98% | Nov 9, 2023 |
| JP Morgan | JP Morgan | Buy → Hold Downgrades $15 → $5 | Buy → Hold | Downgrades | $15 → $5 | +111.86% | Aug 28, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $9 | Strong Buy | Reiterates | $9 | +281.36% | May 5, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $11 → $9 | Strong Buy | Maintains | $11 → $9 | +281.36% | Mar 2, 2023 |
Financial Forecast
Revenue This Year
n/a
from 130.00K
Revenue Next Year
n/a
EPS This Year
-0.87
from -0.93
EPS Next Year
-0.91
from -0.87
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | n/a | n/a | n/a |
| Avg | n/a | n/a | n/a |
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -0.78 | -0.85 | -0.91 |
| Avg | -0.87 | -0.91 | -0.95 |
| Low | -0.95 | -1.00 | -0.98 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.